Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ANGN
- Price
- -
- Stock movement up
- +0.20 (2.04%)
- Company name
- Angion Biomedica Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 301.14M
- Ent value
- 274.02M
- Price/Sales
- 101.94
- Price/Book
- 7.59
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -43.18%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-16
DIVIDENDS
ANGN does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 101.94 |
| Price to Book | 7.59 |
| EV to Sales | 92.76 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 30.11M |
| EPS (TTM) | -1.33 |
| FCF per share (TTM) | -1.87 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.95M |
| Gross profit (TTM) | 653.00K |
| Operating income (TTM) | -29.74M |
| Net income (TTM) | -39.92M |
| EPS (TTM) | -1.33 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 22.11% |
| Operating margin (TTM) | -1006.87% |
| Profit margin (TTM) | -1351.52% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 29.22M |
| Net receivables | 9.98M |
| Total current assets | 40.63M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 41.77M |
| Accounts payable | 692.00K |
| Short/Current long term debt | 297.00K |
| Total current liabilities | 2.03M |
| Total liabilities | 2.10M |
| Shareholder's equity | 39.67M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -30.82M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -56.37M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -100.65% |
| Return on Assets | -95.59% |
| Return on Invested Capital | -100.08% |
| Cash Return on Invested Capital | -141.31% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ANGN | S&P500 | |
| Current price drop from All-time high | -96.11% | -11.70% |
| Highest price drop | -98.14% | -56.47% |
| Date of highest drop | 28 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -79.18% | -10.99% |
| Avg time to new high | 73 days | 12 days |
| Max time to new high | 574 days | 1805 days |
COMPANY DETAILS
Marketcap
301.14M
Marketcap category
Small-cap
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States. The company develops ANG-3070, an oral tyrosine kinase receptor inhibitor for fibrotic diseases in kidney and lung. It also develops ROCK2 inhibitors for fibrotic diseases; CYP11B2, an inhibitor program for aldosterone-related diseases, including resistant hypertension, congestive heart failure, renal fibrosis, and hyperaldosteronism; and CYP26 for the degradation of retinoic acid. Angion Biomedica Corp. was incorporated in 1998 and is based in Uniondale, New York.
Employees
3
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner